Replies to post #327859 on NorthWest Biotherapeutics Inc (NWBO)

[iwasadiver]

Oh, really? You’ve been right all this time haha? My god Junior if you had done what most of us did when we were at .17 cents and keep buying you’d be rich right now like we are instead of continuing to talk crap.

[pqr]

JRIII If you’re right why are u even on this Board? Go invest in AOL or something. PS iwasadiver does not like golf!

[spartex]

Touché iwasadiver.....Touché!

[Karlchen]

why are you talking always THE COMPANY is fraud, have nothing and so on? There isn` t just THE COMPANY !
There are all the cliniciants in 4 countries, there are hundreds of puplications, there are combo trials with keytruda (dont forget colorectal) there are world known people like bosch , liau , ashkan who coold ruin their reputations, there are
no , no need to continue!

[CherryTree1]

Yes everything they have been telling us for the post 2.5 years is true and we now know with all but complete certainty DCVAX will be approved.

We already know the top line results will be positive, at least this good.
How do we know this?
From the still blinded data on all 331 patients
https://nwbio.com/updated-interim-data-from-phase-3-trial-of-dcvax-l-for-glioblastoma/

Survival at 3 years is 28.2%
Survival at 3 years for 41.1% (methylated)

The historical GBM SOC survival
https://www.nature.com/articles/s41598-020-68011-4#:~:text=%25%2C%20respectively36.-,Discussion,glioblastoma%20during%20or%20after%202005.

3-year survival was 11%,
and 5-year survival was 4%

We know from the changes to the European website's late week that the primary end point has change to compare DCVAX treat patients to to recent historical SOC for GBM overall survival.